Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
PTGX holding history
Protagonist Therapeutics, Inc in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings
- Shares (Q2 2026)
- 55,682
- Value
- $6.83M
- % of portfolio
- 0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 55,682 | $6.83M | 0.1% | +41,235+285.4% | Added | Holders |
| Q1 2026 | 14,447 | $1.52M | <0.1% | −2,096−12.7% | Reduced | Holders |
| Q4 2025 | 16,543 | $1.44M | <0.1% | −4,038−19.6% | Reduced | Holders |
| Q3 2025 | 20,581 | $1.37M | <0.1% | +1,109+5.7% | Added | Holders |
| Q2 2025 | 19,472 | $1.08M | <0.1% | +1,850+10.5% | Added | Holders |
| Q1 2025 | 17,622 | $852.2K | <0.1% | −6,096−25.7% | Reduced | Holders |
| Q4 2024 | 23,718 | $915.5K | <0.1% | +11,372+92.1% | Added | Holders |
| Q3 2024 | 12,346 | $555.6K | <0.1% | −2,800−18.5% | Reduced | Holders |
| Q2 2024 | 15,146 | $524.8K | <0.1% | −4,000−20.9% | Reduced | Holders |
| Q1 2024 | 19,146 | $553.9K | <0.1% | −10,854−36.2% | Reduced | Holders |
| Q4 2023 | 30,000 | $687.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 30,000 | $500.4K | <0.1% | +30,000 | New | Holders |